DE502006003030D1 - USE OF INHIBITORS OF THE NA + / H + EXCHANGER, SUBTYPE 5 (NHE5) TO IMPROVE MEMBERSHIP - Google Patents
USE OF INHIBITORS OF THE NA + / H + EXCHANGER, SUBTYPE 5 (NHE5) TO IMPROVE MEMBERSHIPInfo
- Publication number
- DE502006003030D1 DE502006003030D1 DE502006003030T DE502006003030T DE502006003030D1 DE 502006003030 D1 DE502006003030 D1 DE 502006003030D1 DE 502006003030 T DE502006003030 T DE 502006003030T DE 502006003030 T DE502006003030 T DE 502006003030T DE 502006003030 D1 DE502006003030 D1 DE 502006003030D1
- Authority
- DE
- Germany
- Prior art keywords
- nhe5
- subtype
- inhibitors
- exchanger
- membership
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005044815A DE102005044815A1 (en) | 2005-09-20 | 2005-09-20 | Use of inhibitors of Na + / H + exchanger, subtype 5 (NHE5) for memory improvement |
PCT/EP2006/008771 WO2007033774A2 (en) | 2005-09-20 | 2006-09-08 | Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention |
Publications (1)
Publication Number | Publication Date |
---|---|
DE502006003030D1 true DE502006003030D1 (en) | 2009-04-16 |
Family
ID=37102563
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102005044815A Withdrawn DE102005044815A1 (en) | 2005-09-20 | 2005-09-20 | Use of inhibitors of Na + / H + exchanger, subtype 5 (NHE5) for memory improvement |
DE502006003030T Active DE502006003030D1 (en) | 2005-09-20 | 2006-09-08 | USE OF INHIBITORS OF THE NA + / H + EXCHANGER, SUBTYPE 5 (NHE5) TO IMPROVE MEMBERSHIP |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102005044815A Withdrawn DE102005044815A1 (en) | 2005-09-20 | 2005-09-20 | Use of inhibitors of Na + / H + exchanger, subtype 5 (NHE5) for memory improvement |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080234317A1 (en) |
EP (1) | EP1928458B1 (en) |
JP (1) | JP2009508890A (en) |
KR (1) | KR20080046676A (en) |
CN (1) | CN101267822A (en) |
AR (1) | AR056520A1 (en) |
AT (1) | ATE424203T1 (en) |
AU (1) | AU2006294137A1 (en) |
BR (1) | BRPI0616196A2 (en) |
CA (1) | CA2623472A1 (en) |
DE (2) | DE102005044815A1 (en) |
IL (1) | IL189915A0 (en) |
TW (1) | TW200812584A (en) |
WO (1) | WO2007033774A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE036405T2 (en) * | 2008-12-31 | 2018-07-30 | Ardelyx Inc | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10543207B2 (en) | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
SI2983667T1 (en) | 2013-04-12 | 2019-09-30 | Ardelyx, Inc. | Nhe3-binding compounds and methods for inhibiting phosphate transport |
US10647679B2 (en) | 2015-03-15 | 2020-05-12 | Emory University | N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and uses related thereto |
EP3565808A1 (en) | 2017-01-09 | 2019-11-13 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352688A (en) * | 1991-02-14 | 1994-10-04 | The Mount Sinai School Of Medicine Of The City University Of New York | Methods for the treatment of bradyphrenia in parkinson's disease |
US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
JPH08217681A (en) * | 1995-02-13 | 1996-08-27 | Lion Corp | Senile dementia preventing and treating agent |
ZA9610738B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
JP4907817B2 (en) * | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | 4-Phenyl substituted tetrahydroisoquinolines and their use to block reuptake of norepinephrine, dopamine and serotonin |
JP4907818B2 (en) * | 1999-11-03 | 2012-04-04 | エーエムアール テクノロジー インコーポレイテッド | Aryl and heteroaryl substituted tetrahydroisoquinolines and their use to prevent reuptake of norepinephrine, dopamine and serotonin |
WO2003033016A1 (en) * | 2001-10-16 | 2003-04-24 | Jenny Phipps | Use of neurotrophic factors for treating neurodegenerative diseases and cancer |
DE10163914A1 (en) * | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as medicament, and medicament containing them |
US20050070601A1 (en) * | 2003-09-29 | 2005-03-31 | Creative Compounds, Llc | Psychostimulant Effects of Forskolin Including Anorexia |
DE102005044817A1 (en) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
-
2005
- 2005-09-20 DE DE102005044815A patent/DE102005044815A1/en not_active Withdrawn
-
2006
- 2006-09-08 CA CA002623472A patent/CA2623472A1/en not_active Abandoned
- 2006-09-08 WO PCT/EP2006/008771 patent/WO2007033774A2/en active Application Filing
- 2006-09-08 EP EP06791935A patent/EP1928458B1/en not_active Withdrawn - After Issue
- 2006-09-08 AT AT06791935T patent/ATE424203T1/en active
- 2006-09-08 AU AU2006294137A patent/AU2006294137A1/en not_active Abandoned
- 2006-09-08 KR KR1020087006833A patent/KR20080046676A/en not_active Application Discontinuation
- 2006-09-08 BR BRPI0616196-0A patent/BRPI0616196A2/en not_active Application Discontinuation
- 2006-09-08 CN CNA2006800346408A patent/CN101267822A/en active Pending
- 2006-09-08 DE DE502006003030T patent/DE502006003030D1/en active Active
- 2006-09-08 JP JP2008531570A patent/JP2009508890A/en not_active Withdrawn
- 2006-09-18 AR ARP060104074A patent/AR056520A1/en unknown
- 2006-09-18 TW TW095134387A patent/TW200812584A/en unknown
-
2008
- 2008-03-04 IL IL189915A patent/IL189915A0/en unknown
- 2008-03-12 US US12/046,920 patent/US20080234317A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006294137A1 (en) | 2007-03-29 |
BRPI0616196A2 (en) | 2011-06-14 |
AR056520A1 (en) | 2007-10-10 |
CA2623472A1 (en) | 2007-03-29 |
ATE424203T1 (en) | 2009-03-15 |
CN101267822A (en) | 2008-09-17 |
TW200812584A (en) | 2008-03-16 |
EP1928458B1 (en) | 2009-03-04 |
IL189915A0 (en) | 2008-11-03 |
JP2009508890A (en) | 2009-03-05 |
US20080234317A1 (en) | 2008-09-25 |
DE102005044815A1 (en) | 2007-03-22 |
WO2007033774A3 (en) | 2007-06-28 |
KR20080046676A (en) | 2008-05-27 |
EP1928458A2 (en) | 2008-06-11 |
WO2007033774A2 (en) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122522T1 (en) | META ARSENICODE SODIUM FOR USE IN THE MANAGEMENT OF MULTIPLE MYELOMA | |
EA200701396A1 (en) | TRIAZOLOPHTHALASINS AS PDE-2 INHIBITORS | |
EA200970575A1 (en) | COMPOUNDS ON THE BASIS OF 4-PHENYL-6- (2,2,2-TRIFTOR-1-PHENYLETOXI) Pyrimidine and methods for their use | |
ATE490954T1 (en) | ESTER-LINKED GEMINI SURFACTANT COMPOUNDS FOR USE IN GENE THERAPY | |
ATE493986T1 (en) | DIARYLUREAS FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
NO20080129L (en) | Process for the preparation of dihydroquinazolines | |
DOP2006000066A (en) | NEW SALT AND POLYMORPHES OF THE DPP-IV INHIBITOR | |
EA200901609A1 (en) | AMIDES OF PYRAZOLKARBONIC ACID APPLICABLE AS MICROBIOCIDES | |
EA200802213A1 (en) | METHODS OF TREATING BLOOD DISEASES | |
ATE471324T1 (en) | TRIAZOLOPHTHALAZINES | |
FR2884826B1 (en) | POLISHING COMPOSITION AND POLISHING METHOD USING THE SAME | |
CY1112590T1 (en) | 3- [4- (DIVENZO [b, f] [1,4] oxazepin-11-yl) -piperazin-1-yl] -2,2-BIMETAL PROPANIC ACID FOR USE IN ANTI-TREATMENT | |
EA200601568A1 (en) | NEW HYDROXY-8-HETEROARRYFENANTHRIDINES AND THEIR APPLICATION AS PDE4 INHIBITORS | |
ATE388635T1 (en) | USE OF MENADIONE TO ENHANCE THE EFFECTIVENESS OF AGROCHEMICALS | |
FR2900589B1 (en) | POLISHING FELT AND POLISHING METHOD USING THE SAME | |
ATE448234T1 (en) | OLNZAPINE ANALOGUES AND METHODS OF USE THEREOF | |
DE502006003030D1 (en) | USE OF INHIBITORS OF THE NA + / H + EXCHANGER, SUBTYPE 5 (NHE5) TO IMPROVE MEMBERSHIP | |
NO20080265L (en) | 2- (1H-indolylsulfanyl) -arylaminderivater | |
DE602006017367D1 (en) | AMINO-OXO-INDOLYLIDEN COMPOUNDS FOR USE IN THE TREATMENT OF JUCKENDER HEADLINE | |
DE602005015297D1 (en) | USE OF OZONE TO IMPROVE THE KNEWING PROCESS | |
BRPI0720050A2 (en) | 6-OXO-1,6-DIIDROPYRIMIDIN-2-ILAS IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
DE502005003027D1 (en) | ELECTROLYSIS CELL FOR THE MANUFACTURE OF ALKALIMETALL | |
ATE435011T1 (en) | USE OF MORPHOLINO COMPOUNDS TO PREVENT BACTERIAL ATTACK | |
MX2008001541A (en) | Methods for the preparation of hcv polymerase inhibitors. | |
EA200901179A1 (en) | SUBSTITUTED TETRAHYDROCHINOLINES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8372 | Publication of ep patent withdrawn |